New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Aims to boost speed & precision in patient care
_and_Dr__D_Nageshwar_Reddy_(AIG_Hospitals)_256_384.jpg)
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Subscribe To Our Newsletter & Stay Updated
